Columbus, Ohio – The Department of Justice and the state of Ohio filed a civil antitrust lawsuit Friday against OhioHealth, alleging the Columbus-based health system is using its market power to stifle competition and drive up healthcare costs for consumers. The lawsuit centers on contract terms that regulators claim limit insurers’ ability to offer more affordable plans and prevent other hospitals from negotiating lower prices.
The action marks the latest in a growing wave of federal and state scrutiny of hospital consolidation and its impact on healthcare affordability. Concerns are mounting nationally that hospital systems are leveraging their size to extract higher prices from insurers, ultimately passed on to patients. This case specifically focuses on what regulators describe as anticompetitive practices employed by OhioHealth, one of the largest healthcare providers in central Ohio.
Allegations of Anti-Competitive Practices
According to the Department of Justice’s announcement, OhioHealth allegedly imposes contract terms that include “anti-steering” provisions and “all-or-nothing” contracting. Anti-steering provisions prevent insurers from incentivizing patients to choose lower-cost providers, while all-or-nothing contracts require insurers to include all of OhioHealth’s hospitals in their networks, even if some are more expensive than others.
“These practices effectively box out competition,” explained Omeed Assefi, acting assistant attorney general of the Justice Department’s Antitrust Division, in a statement. “They prevent consumers from choosing lower-cost health plans and severely limit consumers’ access to price information.” The lawsuit argues that these restrictions hinder the development of innovative healthcare plans and limit the ability of other hospitals to compete effectively.
Impact on Consumers and Insurers
The core argument of the lawsuit is that OhioHealth’s contracts artificially inflate healthcare costs. By preventing insurers from steering patients to lower-cost options and requiring them to include all of its facilities, OhioHealth is able to command higher reimbursement rates. This, in turn, leads to higher premiums for consumers and increased healthcare spending overall.
The lawsuit doesn’t specify the exact financial impact on consumers, but regulators suggest the anticompetitive practices have a significant and detrimental effect on the Ohio healthcare market. The Ohio Attorney General’s office is working in conjunction with the DOJ, signaling the state’s commitment to addressing healthcare affordability concerns. The legal action seeks to halt these practices and restore competition to the market.
What are ‘Anti-Steering’ and ‘All-or-Nothing’ Contracts?
These contract provisions are becoming increasingly common points of contention in antitrust cases involving hospital systems. “Anti-steering” clauses prohibit insurers from designing plans that encourage patients to utilize more affordable care settings, such as ambulatory surgery centers or lower-cost hospitals. “All-or-nothing” contracts, conversely, force insurers to include all facilities within a health system’s network, even if some are significantly more expensive than others, effectively limiting consumer choice.
OhioHealth’s Response
As of Saturday, February 22, 2026, OhioHealth has not released a comprehensive public statement addressing the specific allegations outlined in the lawsuit. However, the health system acknowledged the legal action in a brief statement, asserting its commitment to providing high-quality, affordable care to the community. OhioHealth maintains that its contracts are designed to ensure access to a comprehensive network of services and maintain the financial stability of the system, allowing it to continue investing in patient care.
Broader Trends in Healthcare Antitrust Enforcement
The lawsuit against OhioHealth is part of a broader trend of increased antitrust enforcement in the healthcare industry. The Biden administration has made healthcare competition a priority, and the DOJ and Federal Trade Commission (FTC) have signaled a willingness to challenge hospital mergers and anticompetitive practices. This case follows similar actions taken against other large health systems across the country, reflecting a growing concern that hospital consolidation is contributing to rising healthcare costs.
Experts suggest this increased scrutiny is a response to decades of hospital consolidation, which has left many markets dominated by a few large players. The goal of these antitrust efforts is to restore competition, lower prices, and improve the quality of care for consumers. The outcome of the OhioHealth case could set a precedent for future antitrust enforcement actions in the healthcare sector.
The next step in the legal process will involve discovery and potential court hearings. A trial date has not yet been set. Consumers seeking information about their healthcare options and rights are encouraged to contact the Ohio Attorney General’s office or the Department of Justice.
This is a developing story. Check back for updates as more information becomes available.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical or legal advice.
